Please login to the form below

Not currently logged in
Email:
Password:

Former FDA adviser joins Precision for Medicine

Vicki Seyfert-Margolis appointed chief of science and strategy at life science research company

Precision for Medicine Vicki Seyfert-Margolis Precision for Medicine has appointed former US FDA senior adviser Dr Vicki Seyfert-Margolis to the role of chief of science and strategy.

Dr Seyfert-Margolis served as senior adviser, regulatory science and innovation at the US regulator, reporting directly to the commissioner.

During this time, she led the FDA's regulatory science and personalised medicine initiative, as well as strategies for promoting innovation in drug development.

Prior to her time with the FDA, Dr Seyfert-Margolis was chief science officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.

In her new role at Precision for Medicine, which provides research support to life science companies, Dr Syfert-Margolis will guide the company's scientific strategy and provide insight and support for its clients.

“Precision for Medicine shares my vision for the future of healthcare - one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development,” said Dr Seyfert-Margolis.

19th April 2013

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...